Provectus Biopharmaceuticals
Heather Raines CPA serves as the Chief Financial Officer and Controller at Provectus Biopharmaceuticals. Prior to this, Heather held roles such as VP of Finance at B DRY WATERPROOFING and AMT Business Unit Controller at AMETEK Advanced Measurement Technologies. With extensive experience in finance and accounting, Heather has managed financial functions for companies with annual sales exceeding $100 million and demonstrated proficiency in various financial areas such as financial analysis, audits, budgeting, and reporting. Heather holds a Master's degree in Accounting from Strayer University and a Bachelor's degree in Accounting from the University of Tennessee.
This person is not in any offices
Provectus Biopharmaceuticals
Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer, and breast cancer. Provectus’ investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers.